Formycon AG (ETR: FYB)
Germany
· Delayed Price · Currency is EUR
51.30
+0.30 (0.59%)
Dec 20, 2024, 5:36 PM CET
Formycon AG Employees
Formycon AG had 238 employees as of December 31, 2023. The number of employees increased by 33 or 16.10% compared to the previous year.
Employees
238
Change (1Y)
33
Growth (1Y)
16.10%
Revenue / Employee
€254,393
Profits / Employee
€267,351
Market Cap
905.80M
Employees Chart
Formycon AG News
- 12 days ago - EQS-News: MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region - Wallstreet:Online
- 22 days ago - Formycon AG (XTER:FYB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges - GuruFocus
- 22 days ago - Q3 2024 Formycon AG Earnings Call Transcript - GuruFocus
- 23 days ago - Formycon's 2024 Growth Soars with Strong Nine-Month Results - Wallstreet:Online
- 23 days ago - EQS-News: Formycon reports nine-month results for 2024 and continues growth trajectory with further operational successes - Wallstreet:Online
- 4 weeks ago - EQS-News: Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences - Wallstreet:Online
- 4 weeks ago - EQS-News: Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea under the tradenames AHZANTIVE and Baiama - Wallstreet:Online
- 5 weeks ago - EQS-Adhoc: Aflibercept-Biosimilar FYB203 / AHZANTIVE/ Baiama receives positive CHMP Opinion from EMA - Wallstreet:Online